Working… Menu
Help guide our efforts to modernize
Send us your comments by March 14, 2020.

Y- Shaped Pegylated Interferon (YPEG-IFNα-2a) Plus Ribavirin in Egyptian Patients With Untreated Chronic Hepatitis C

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01327729
Recruitment Status : Unknown
Verified March 2011 by BioGeneric Pharma.
Recruitment status was:  Recruiting
First Posted : April 4, 2011
Last Update Posted : April 4, 2011
Xiamen Amoytop Biotech Co., Ltd.
Information provided by:
BioGeneric Pharma

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : April 2011
Estimated Study Completion Date : May 2013